Addictions, Drug & Alcohol Institute

Front Page


May 23, 2022

ADAI in the News: How to Keep Loved Ones Safe from Fentanyl (NY Times)

Father talking to son on steps

ADAI Principal Research Scientist Caleb Banta-Green was interviewed by Melinda Wenner Moyer at the New York Times for this piece about how to talk about opioids with your family. Dr. Banta-Green talks about how widely and safely fentanyl is used in hospitals – “most people who have had a day surgery have had fentanyl” –…


May 20, 2022

Webinar June 2: Fentanyl and Opioid Overdose Prescribing for School Personnel

Graphic repeating the title, date, and time of the webinar

June 2, 2022 | 1:30-3:00pm PT Presenters: ADAI Continuing Education Specialist Alison Newman, MPH, Sean Hemmerle (WA DOH) and Robyn Smith (King County Behavioral Health & Recovery) This training, sponsored by the Washington Office of Superintendent of Public Instruction (OSPI), will provide an overview of the prevalence of fentanyl and how it affects the rates…


May 19, 2022

Webinar June 10: Questions and Answers from Patients About Psychedelics for SUDs

Upcoming webinar

Where Can I Get Psilocybin for My Opioid Use Disorder? A Review of Questions and Answers from Patients About Psychedelics for SUDsJune 10, 2022 | 12:00-1:00pm PT This session is the third in ADAI’s quarterly “What’s the Latest” series addressing medications for opioid use disorder. Presented by Mark Duncan, MD, this installment will focus on…


May 13, 2022

New Research: Negative Attitudes About Medications for OUD Among Criminal Legal Staff

Image of guard in prison with citation of paper Negative Attitudes About Medications for OUD Among Criminal Legal Staff

Stigma is a barrier to the treatment of opioid use disorder (OUD) in the criminal legal system, and how staff think about criminal involvement and addiction in general might explain their negative attitudes about medications for OUD (MOUD), such as buprenorphine or methadone, as well. This new paper, coauthored by ADAI Assistant Professor Mandy Owens,…


May 10, 2022

Transforming Our Communities: Sharing Innovations to Reduce Harms for People Who Use Drugs: June 7-8, 2022

Illustration of diverse group of people with text "Transforming Our Communities, June 7-8, 2022"

Registration is open for our 3rd annual Transforming Our Communities Gathering, June 7-8, 2022, 8:30am -12:30pm PT. This 2-day virtual event aims to bring a wide range of participants together to understand the perspectives of people who use drugs, understand the importance of equitable access to care and services, build partnerships and connect people within…


May 9, 2022

Why ADAI is Using “Cannabis” Instead of “Marijuana”

Blocks spelling out "Words matter"

Words matter. And that’s why we’re working to replace the term “marijuana” on ADAI websites and resources with “cannabis,” following the recent passing of Washington State’s HB 1210. This new law makes Washington State a pioneer on removing discriminatory language from cannabis-related official documents in the United States. The term “marijuana” came into popular usage in the U.S….


May 5, 2022

Virtual Panel: More Than Just Pipes: Lessons from the Field About Safer Smoking Supplies (May 16)

Picture of safer smoking supplies like a pipe and foil and title of related webinar

ADAI’s Center for Community-Engaged Drug Education, Epidemiology and Research (CEDEER) hosted an interactive virtual panel about how organizations can use distribution of safer smoking supplies to reach people who smoke opioids or stimulants. In this session, experts from the People’s Harm Reduction Alliance and Tacoma Needle Exchange/Dave Purchase Project shared their strategies and answer your…


May 4, 2022

New from ADAI: Using Alcohol & Cannabis Simultaneously More Harmful for Youth Than Use of Either Alone

New from CSHRB & ADAI: Simultaneous alcohol and marijuana use among young adults: A scoping review...

Using alcohol and cannabis simultaneously – taking them at the same time to generate overlapping effects – produces greater negative consequences than use of either substance alone, according to this new scoping review published in Alcohol Research: Current Reviews. For this review, researchers from the UW Center for the Study of Health and Risk Behaviors…


Get News, Events, & Research Updates on Opioids & Stimulants from CEDEER

Subscribe to our newsletter

The Center for Community-Engaged Drug Education, Epidemiology and Research (CEDEER) group at ADAI joins research with the “real-world” to generate innovative, evidence-based, and person-centered responses to the use of opioids, stimulants and other illicit substances. The group works to collect and share knowledge gained from research, local data, clinical expertise, and personal lived experiences of…


May 2, 2022

ADAI in the News: High-Potency Cannabis a Concern in WA and CO

Cannabis pen

ADAI cannabis expert Beatriz Carlini, PhD, MPH was interviewed for a national NBC News article exploring the impact of high-THC concentration products in states that have legalized cannabis for retail sale, like Washington and Colorado. Dr. Carlini, who was part of a team of UW and WSU researchers who put together a consensus statement and…



Next page